European Confederation of Pharmaceutical Entrepreneurs
EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.
European Confederation of Pharmaceutical Entrepreneurs has 69 disclosed EU lobbying meetings from 2019-04-03 to 2026-09-04: 45 with the European Commission and 24 with Members of the European Parliament. Source: EU Transparency Register no. 87600691525-93, Commission disclosures and MEP declarations.
Lobbying profile
as declared 2026-05-13- Category
- Trade and business associations
- Legal status
- AISBL
- Declared lobbying cost
- €800,000
- Lobbying FTEs
- 4.2
- Members
- 2
Files it’s lobbying on
The org's disclosed policy areas, ranked by number of meetings.
Declared fields of interest
Business and industry · Competition · Consumers · Digital economy and society · Economy, finance and the euro · Food safety · Institutional affairs · Public health · Research and innovation · Single market · Trade
At a glance
The officials and MEPs most often met, by disclosed-meeting count.
- Stella Kyriakides10
- Maya Matthews5
- Olivér Várhelyi5
- Laszlo Andrejko4
- Thierry Breton4
Disclosed meetings
Newest first, showing the most recent 60 of 69. EC = European Commission, EP = Member of the European Parliament.
- EU Health Policysource ↗
- EU Pharma Policiessource ↗
- 2026-07-07ECMatthias Schuppe · Acting Head of UnitThe European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) reached out to discuss the evidence requirements for possible inclusion of liquid biopsy in future updates of the Council Recommendation (CR) on cancer screeningsource ↗
- 2026-07-02ECMaya Matthews · Head of UnitExchange of views on implementation of the HTA Regulationsource ↗
- 2026-06-10ECKarolina Tomaszewska-Boillot · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-06-10ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-06-10ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-06-10ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-06-10ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-05-06ECMaya Matthews · Head of UnitExchange of views on reaching out to Small and Medium Enterprises (SMEs) under the Health Technology Assessment (HTA) Regulationsource ↗
- Critical medicinesource ↗
- Strengthening EU Action on Rare Diseases and Life Sciences Competitivenesssource ↗
- Biotech Actsource ↗
- Rare diseasessource ↗
- Health Policysource ↗
- 2026-04-16ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-04-16ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-04-16ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-04-16ECKatri Teedumäe · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-04-16ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- 2026-04-16ECKarolina Tomaszewska-Boillot · Cabinet of Commissioner Olivér VárhelyiHealth industry roundtablesource ↗
- HTAsource ↗
- Exchange of Views with the European Confederation of Pharmaceutical Entrepreneurs on the UCPM and Health Preparednesssource ↗
- 2026-02-11ECMaya Matthews · Head of UnitExchange of views on operations under the HTA Regulation with a focus on joint clinical assessments (JCAs)source ↗
- 2025-10-22ECMaya Matthews · Head of UnitExchange of views on joint clinical assessment and joint scientific consultations under the HTA Regulation.source ↗
- 2025-10-16ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiSituation of medium sized innovative pharma sectorsource ↗
- 2025-10-16ECKatri Teedumäe · Cabinet of Commissioner Olivér VárhelyiSituation of medium sized innovative pharma sectorsource ↗
- 2025-10-16ECLaszlo Kristoffy · Cabinet of Commissioner Olivér VárhelyiSituation of medium sized innovative pharma sectorsource ↗
- 2025-10-02ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- 2025-10-02ECJana Dabbelt · Cabinet of Commissioner Olivér VárhelyiAll pressing portfolio topicssource ↗
- production of critical medicines in the EUsource ↗
- Critical Medicines Actsource ↗
- EU Health Care Policiessource ↗
- APA Training on CBRN Threatssource ↗
- Health policysource ↗
- 2025-07-03ECAnn-Sofie Ronnlund · Cabinet of Commissioner Ekaterina ZaharievaLife sciencessource ↗
- 2025-06-17ECOlivér Várhelyi · Cabinet of Commissioner Olivér VárhelyiEU biotech policysource ↗
- 2025-06-17ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiEU biotech policysource ↗
- Critical Medicines Actsource ↗
- Introductory Meetingsource ↗
- Health securitysource ↗
- 2025-04-29ECLaszlo Andrejko · Cabinet of Commissioner Olivér VárhelyiBiotechsource ↗
- Pharmaceutical Industry in the EUsource ↗
- 2025-03-27ECMaya Matthews · Head of UnitEU HTA regulationsource ↗
- Health policysource ↗
- Healthsource ↗
- Introductory meetingsource ↗
- 2024-11-21ECMarc Lemaitre · Director-GeneralEUCOPE’s priorities and the perspective of the smaller innovative pharmaceutical industrysource ↗
- European health policysource ↗
- Life sciences industrysource ↗
- Generel exchange (staff level)source ↗
- 2022-05-18ECGiorgos Rossides · Cabinet of Commissioner Stella KyriakidesExchange of views on the upcoming reform of the pharmaceutical legislationsource ↗
- 2020-11-06ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemicsource ↗
- 2020-09-30ECKarolina Herbout-Borczak · Cabinet of Commissioner Stella KyriakidesCall with pharmaceutical and medical device supply Chain on COVID-19source ↗
- 2020-06-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemicsource ↗
- 2020-06-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesCall with pharmaceutical and medical device industry associations on COVID-19source ↗
- 2020-05-29ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-05-15ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-05-08ECStella Kyriakides · Cabinet of Commissioner Stella KyriakidesVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
- 2020-05-08ECThierry Breton · Cabinet of Commissioner Thierry BretonVideo call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreaksource ↗
Frequently asked
How many EU lobbying meetings has European Confederation of Pharmaceutical Entrepreneurs disclosed?
European Confederation of Pharmaceutical Entrepreneurs (EU Transparency Register no. 87600691525-93) appears in 69 disclosed meetings with EU officials and MEPs between 2019-04-03 and 2026-09-04: 45 with the European Commission and 24 with Members of the European Parliament.
What does European Confederation of Pharmaceutical Entrepreneurs lobby on?
European Confederation of Pharmaceutical Entrepreneurs's disclosed EU meetings most often concern Health, Technology. Every meeting and its topic is listed with its official source on this page.
Who does European Confederation of Pharmaceutical Entrepreneurs meet in Brussels?
Across its disclosed meetings, European Confederation of Pharmaceutical Entrepreneurs has met Commission officials including Stella Kyriakides, Maya Matthews, Olivér Várhelyi, and MEPs including METZ Tilly, SOKOL Tomislav, NIEBLER Angelika. These are counts of officially disclosed meetings, not a measure of influence.
Primary sources
Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.
Related on the graph
The same footprint, mapped onto the topics and files it touches.
Get the EU lobbying brief
We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.
See your company’s overlap with European Confederation of Pharmaceutical Entrepreneurs — and the rest of the corpus.
Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.